# Module 4 — Stage 1 Readiness Checklist & Verification Gate

**Date:** 2026-10-14  
**Phase:** Module 4 Transition Verification (Stage 0 -> Stage 1)  
**Readiness Verdict:** **100% VERIFIED & READY FOR STAGE 1**  
**Gate 0 Status:** **PASSED & AUTHORIZED BY USER**  
**Stage 1 Status:** **ACTIVE (Implementation & Training Configuration Preparation)**  

---

## 1. Readiness Verification Matrix

Every required condition has been substantiated by direct file inspection, user ratification, and clinical criteria verification:

| # | Readiness Criterion | Verification Status | Evidentiary Basis |
| :---: | :--- | :---: | :--- |
| **1** | **RFB Rules Unambiguous** | **PASSED & APPROVED** | Formally defined along ordered sequence $\mathcal{S}$; User approved Option A (First Failure Configuration accompanied by Transition Pair $(c_{k-1} \to c_k)$ and Last Passing Configuration; non-monotonic recovery tracked with `RECOVERY_DETECTED = True`). |
| **2** | **DFB Rules Unambiguous** | **PASSED & APPROVED** | Defined along sequence $\mathcal{S}$ via Retained Performance Ratio $\text{RPR}(c_k) = \frac{\text{MacroF1}(c_k)}{\text{MacroF1}_{12}}$ with primary threshold $\gamma = 0.80$; zero-denominator and recovery rules specified (`reports/module4_evaluation_protocol.md` §5.2). |
| **3** | **Decoupling-Gap Convention Explicit** | **PASSED & APPROVED** | User approved Option A: Dual reporting of Step Gap $\Delta_{\text{steps}} = k_{\text{DFB}} - k_{\text{RFB}}$ and Physical Lead Gap $\Delta_{\text{leads}} = l_{\text{RFB}} - l_{\text{DFB}}$. Positive gap denotes dangerous diagnostic persistence beyond reasoning failure (`reports/module4_evaluation_protocol.md` §5.3). |
| **4** | **Claim Statuses & Counting Reproducible** | **PASSED & APPROVED** | User approved Option A: Micro-aggregation primary across test records with Macro-aggregation sensitivity analysis; atomic claim deduplication enforced; mutually exclusive partition $N_{\text{total}} = N_{\text{supp}} + N_{\text{contra}} + N_{\text{unavail}}$ (`reports/module4_evaluation_protocol.md` §4.1). |
| **5** | **Evidence Criteria Traceable (U-04 Verified)** | **PASSED & VERIFIED** | Contiguous-lead requirement ($\ge 2$ contiguous leads with ST elevation $\ge 0.10\text{ mV}$) and anatomical territories (`inferior`, `septal`, `anterior`, `lateral`) verified in `src/reasoning/clinical_taxonomy.py` lines 24–33, `reports/evidence_observability_config.json` lines 130–145, and `PROJECT_PHASES_SPECIFICATION.md` line 335. Strict clinical criteria retained without relaxation. |
| **6** | **Test-Set Quarantine Formalized** | **VERIFIED** | Strict 4-split policy: Train (25,825 records), Validation (3,688 records), Test (7,375 records x 7 variants = 51,625 arrays). Test split strictly quarantined until Stage 4 single-pass evaluation (`reports/module4_evaluation_protocol.md` §8). |
| **7** | **Baselines & Calibration Documented** | **VERIFIED** | Four baselines pre-registered (B-1: Linear probe, B-2: Rule engine, B-3: Control Transformer, B-4: Experimental Transformer). `BCEWithLogitsLoss` over 8 independent logits ratified; validation-only temperature calibration specified (`reports/module4_evaluation_protocol.md` §6, §8). |
| **8** | **AURDC & AUTDC Reproducible** | **VERIFIED** | Trapezoidal integration convention over $[12, 10, 8, 6, 4, 2, 1]$ documented with divisor 11; undefined point truncation rule specified (`reports/module4_evaluation_protocol.md` §7). |
| **9** | **Module 3 Non-Monotonicity Preserved** | **VERIFIED** | Finding F-09 enshrined in protocol §2: 4-lead cosine similarity ($0.904078$) is higher than 6-lead ($0.877548$) due to V1 septal retention; globally monotonic drift claims permanently prohibited (`reports/module4_evaluation_protocol.md` §2). |
| **10** | **Frozen Modules 1–3 Untouched** | **VERIFIED** | Hashes for `runs/module1_v2/`, `runs/module2_v1/`, and `runs/module3_v1/` match freeze manifests; zero modifications applied to upstream modules (`reports/module4_stage0_inspection_report.md` §1). |
| **11** | **No Training or Test Evaluation Initiated** | **VERIFIED** | Zero model parameters trained; zero test labels accessed; pipeline halted at Stage 0 (`reports/module4_stage0_inspection_report.md` §1). |
| **12** | **All Decisions Formally Resolved** | **VERIFIED** | Decisions U-01, U-02, U-03 approved; U-04 verified and ratified in `reports/module4_unresolved_decisions.md`. Zero unresolved scientific questions remain. |

---

## 2. Gate 0 Authorization & Stage 1 Transition

```
+---------------------------------------------------------------------------------------------------+
|                                  GATE 0 TRANSITION STATUS                                         |
|                                                                                                   |
|                       GATE 0: PASSED  |  STAGE 1: AUTHORIZED & ACTIVE                             |
|                                                                                                   |
| Mandate for Stage 1:                                                                              |
| 1. Update multi-cohort loader and reasoning dataset to bind to frozen runs/module1_v2,           |
|    runs/module2_v1, and runs/module3_v1.                                                          |
| 2. Enforce strict 70:10:20 partitioning (25,825 train, 3,688 val, 7,375 test quarantined).        |
| 3. Integrate deterministic rule-based observation extraction for training/validation records.      |
| 4. Update configs/control_path_training_config.json to reflect frozen contracts.                   |
| 5. Run verification tests to validate zero leakage, data pipeline, and model architecture.        |
| 6. Stop at Stage 1 Completion Gate (Pre-Training Verification Gate) before model training.       |
+---------------------------------------------------------------------------------------------------+
```
